Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic corticosteroid prophylaxis for postembolization syndrome after hepatic transarterial chemoembolization in hepatocellular carcinoma
TCTR20170906004Phase 2Completed
- Sponsor
- N/A
- Start
- Sep 2017
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hepatocellular carcinoma (HCC) (2 arms), sponsored by N/A. Started Sep 2017; status: completed.
02
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on TCTR20170906004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170906004.